{site_meta && site_meta.display_name} Logo

NewMediaWire

NewMediaWire distributes press releases on behalf of hundreds of publicly traded companies, as well as private corporations, non-profits and other public sector organizations. Founded and staffed by industry veterans, we offer a full complement of services including specialized delivery to financial sites and posting of photos and multimedia content. In addition, NewMediawire offers international and specialized services such as IR websites and industry specific distribution.

RSS Feed for NewMediaWire

LogicMark Strives To Drive Growth In Personal Safety Through Innovation

November 3, 2025 By Johnny Rice, Benzinga DETROIT, MICHIGAN - November 3, 2025 (NEWMEDIAWIRE) - Chia-Lin Simmons, CEO of LogicMark (OTC: LGMK), was recently interviewed by Benzinga. LogicMark is a leading provider of personal emergency response systems (PERS), health communications devices and IoT technologies, within a Connected Care Platform.


Medical Devices Designed For Every Possibility

November 3, 2025 By Johnny Rice, Benzinga DETROIT, MICHIGAN - November 3, 2025 (NEWMEDIAWIRE) - Chia-Lin Simmons, CEO of LogicMark (OTC: LGMK), was recently a guest on Benzinga’s All-Access. LogicMark is a leading provider of personal emergency response systems (PERS), health communications devices and IoT technologies to create a connected care platform.


GeoVax Announces Relocation of Corporate Headquarters and Laboratory Operations to Support Accelerated Growth and Pipeline Advancement

November 3, 2025Relocations Strengthen Ties to Georgia’s Bio-Ecosystem and Position GeoVax for Late-Stage Development and Market Readiness ATLANTA, GA - November 3, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and multi-antigen vaccines against cancers and infectious diseases, today announced relocations of its corporate headquarters and laboratory operations to new facilities in the Atlanta metropolitan area.


ABVC BioPharma Reports 230% YoY Licensing Revenue Growth and 181% Asset Expansion in Q3 2025

November 3, 2025SILICON VALLEY, CA - November 3, 2025 (NEWMEDIAWIRE) - ABVC BioPharma, Inc.. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company developing therapeutic solutions in central nervous system (CNS), ophthalmology, and oncology/hematology indications, today announced its financial results for the quarter ended September 30, 2025, and provided an update on recent corporate developments.


One World Products Secures OEM Approval for Cellulose Fiber-Filled Masterbatch for Future Vehicle Programs

November 3, 2025Milestone Caps a Strong October That Included Surpassing 100,000 Pounds of Rubber Shipments and Expanded Ecosystem Partnerships DETROIT, MI - November 3, 2025 (NEWMEDIAWIRE) - One World Products, Inc. (OTC: OWPC), soon to be renamed Isiah Enterprises, announced that a major automotive OEM has approved the company’s cellulose fiber-filled masterbatch for use in near-future vehicle models.


Optimal Cardiovascular Health Among People With Type 2 Diabetes May Offset Dementia Risk

November 3, 2025Research Highlights: Optimal cardiovascular health, based on the American Heart Association’s Life’s Essential 8 metrics, may decrease the risk of mild cognitive impairment and dementia for adults with Type 2 diabetes. Among adults with both Type 2 diabetes and a high genetic risk for dementia, researchers found that having moderate or high cardiovascular health, compared to having low cardiovascular health, greatly lowered the risk of developing mild cognitive impairment and dementia over 13 years.


Assessing Heart-Pumping Glitch May Reduce Stroke Risk In Adults With Heart Muscle Disease

November 3, 2025Research Highlights: People with a condition in which protein build up stiffens heart walls – called transthyretin amyloid cardiomyopathy – were more likely to have a stroke if they also had a mechanical malfunction in the atrial chamber of their heart. A noninvasive risk assessment tool may help identify people with the condition who are at high stroke risk and might benefit from preventive measures, according to researchers.


Healthy Lifestyle Combined With Newer Diabetes Medications Lowered Cardiovascular Risk

November 3, 2025Research Highlights: For people with Type 2 diabetes, following at least six healthy lifestyle habits when taking GLP-1 RA medications can lower their risk of heart attack, stroke, hospital visits due to cardiovascular disease and death, more than medication alone or healthy lifestyle changes alone. A study of more than 63,000 military veterans with Type 2 diabetes who took GLP-1 RA medications found that those with at least six healthy lifestyle habits had a 50% lower risk of serious cardiovascular events when compared to veterans with a lower adherence to a healthy lifestyle who were receiving standard diabetes care but not taking GLP-1 RA medication.


Long-term Use Of Melatonin Supplements To Support Sleep May Have Negative Health effects

November 3, 2025Research Highlights: A review of 5 years of health records for more than 130,000 adults with insomnia who had used melatonin for at least a year found they were more likely to be diagnosed with heart failure, require hospitalization for the condition or die from any cause. The association between melatonin and increased risk of heart failure or death found in this study, which cannot prove a cause-and-effect relationship, raises safety concerns about the use of melatonin, which is widely available, and may warrant more research on melatonin to assess its cardiovascular safety, researchers said.


Analyzing 3 Biomarker Tests Together May Help Identify High Heart Disease Risk Earlier

November 3, 2025Research Highlights: Adults with elevated levels of three biomarkers for heart disease—lipoprotein a (also called Lp(a)), remnant cholesterol and high-sensitivity C-reactive protein (hsCRP)—had nearly triple the risk of heart attack compared to those without elevated levels. In addition, people with elevated levels of only one of the three biomarkers had a 45% increased risk of heart attack and those with elevated levels of two biomarkers had double the risk.


Low-dose Aspirin Linked To Lower Cardiovascular Event Risk For Adults With Type 2 Diabetes

November 3, 2025Research Highlights: Adults with Type 2 diabetes (T2D) and at moderate or high risk of cardiovascular disease who took low-dose aspirin were less likely to experience a serious cardiovascular event, including a heart attack, stroke or death, than peers who did not take aspirin. Any low-dose aspirin use was associated with significantly lower risk of having a heart attack or stroke compared to no low-dose aspirin use, with greater benefit observed among those individuals who took it the most often.


Exposure to More Artificial Light at Night May Raise Heart Disease Risk

November 3, 2025Research Highlights Higher levels of exposure to artificial light at night were linked to increased stress-related activity in the brain, inflamed arteries and a higher risk of heart disease, according to a small study of adults in Boston. Nighttime light pollution appeared to affect heart health, making it an environmental factor that could be changed to help reduce heart disease in communities with higher levels of nighttime light, researchers said.


An AI tool Detected Structural Heart Disease in Adults Using a Smartwatch

November 3, 2025Research Highlights: An artificial intelligence (AI) tool detected structural heart problems using a single-lead ECG captured by the electrical heart sensor on the back and digital crown of a smartwatch. The AI algorithm was tested on single-lead ECGs taken on a smartwatch in a group of 600 adults.


FWD Group Reports Strong New Business Growth

November 3, 2025Multiple Strategic Capital Management Actions Boost Financial Strength, Reducing Leverage and Financing Costs HONG KONG - November 2, 2025 (NEWMEDIAWIRE) - FWD Group Holdings Limited (“FWD Group” or “FWD”) today announced strong new business growth for the nine months ended 30 September 2025[1]. New business sales were up 37 per cent to US$1.


Autumn Lighting Fair, Outdoor and Tech Light Expo, Eco Expo Asia Draw Some 62,000 Buyers

October 31, 2025Global Brands Launch Innovative Products Survey Reveals AI, Smart City Development and Technological Advancement as Driving Forces in the Lighting Industry Two major lighting fairs and Eco Expo Asia have concluded with success, attracting some 62,000 buyers from 141 countries and regions The spotlight Hall of Connected Lighting featured some 70 top global brands. An AI smart lighting exhibitor at the Autumn Lighting Fair successfully confirmed an onsite order with a Thai buyer worth up to RMB8 million, double the value of their sales at the fair last year In an independent on-site survey, 61% of lighting industry respondents expect overall sales to grow in the next one to two years.


Hong Kong Delegation Concludes Mission in Riyadh

October 31, 2025Participation in FII Summit and business engagements to strengthen Hong Kong-Saudi economic cooperation HONG KONG - October 31, 2025 (NEWMEDIAWIRE) - A business delegation jointly organised by the Government of the Hong Kong Special Administrative Region (HKSAR) and the Hong Kong Trade Development Council (HKTDC) and led by Financial Secretary Paul Chan visited Riyadh, the capital of Saudi Arabia, from 27 to 31 October. The delegation attended the Future Investment Initiative (FII) Summit and met with senior government officials and business leaders to promote collaboration between Hong Kong and Saudi Arabia in areas, such as innovation and technology (I&T), smart city, AI, fintech and biotechnology, supporting the goals of Saudi Arabia’s Vision 2030.